<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Urologiia</journal-id><journal-title-group><journal-title xml:lang="en">Urologiia</journal-title><trans-title-group xml:lang="ru"><trans-title>Урология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1728-2985</issn><issn publication-format="electronic">2414-9020</issn><publisher><publisher-name xml:lang="en">Bionika Media</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">680399</article-id><article-id pub-id-type="doi">10.18565/urology.2024.6.157-164</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Literature reviews</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Обзоры литературы</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Symptomatic urinary tract infections in pregnant and non-pregnant women. What is common and what are the differences?</article-title><trans-title-group xml:lang="ru"><trans-title>Симптоматические инфекции мочевыводящих путей у беременных и небеременных пациенток. Что общего и в чем различия?</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Lokshin</surname><given-names>K. L.</given-names></name><name xml:lang="ru"><surname>Локшин</surname><given-names>К. Л.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Head of the Center for Operative Urology, Oncourology and Andrology</p></bio><bio xml:lang="ru"><p>доктор медицинских наук, руководитель центра оперативной урологии, онкоурологии и андрологии</p></bio><email>k_lokshin@hotmail.com</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">OOO «GMS Hospital»</institution></aff><aff><institution xml:lang="ru">ООО «Джи Эм Эс Хоспитал»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2024-12-10" publication-format="electronic"><day>10</day><month>12</month><year>2024</year></pub-date><issue>6</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>153</fpage><lpage>159</lpage><history><date date-type="received" iso-8601-date="2025-05-25"><day>25</day><month>05</month><year>2025</year></date><date date-type="accepted" iso-8601-date="2025-05-25"><day>25</day><month>05</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Bionika Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2024, ООО «Бионика Медиа»</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Bionika Media</copyright-holder><copyright-holder xml:lang="ru">ООО «Бионика Медиа»</copyright-holder></permissions><self-uri xlink:href="https://journals.eco-vector.com/1728-2985/article/view/680399">https://journals.eco-vector.com/1728-2985/article/view/680399</self-uri><abstract xml:lang="en"><p>This review outlines current approach to diagnostics and treatment of symptomatic urinary tract infections in pregnant and non-pregnant women.</p> <p>Using data from modern studies and the most current clinical guidelines, an analysis of changes in the resistance of pathogens causing cystitis and pyelonephritis in women was carried out.</p> <p>The current principles of selection and rules for antibiotic therapy in pregnant and non-pregnant patients with symptomatic urinary tract infections were reviewed.</p></abstract><trans-abstract xml:lang="ru"><p>Данный обзор посвящен особенностям диагностики и лечения симптомных инфекций мочевыводящих путей у беременных и небеременных женщин.</p> <p>С использованием данных современных исследований и самых актуальных клинических рекомендаций проведен анализ изменений резистентности возбудителей инфекций мочевыводящих путей при циститах и пиелонефритах у женщин.</p> <p>Рассмотрены актуальные принципы подбора и правила проведения антибиотикотерапии у беременных и небеременных пациенток при симптомных инфекциях мочевыводящих путей.</p></trans-abstract><kwd-group xml:lang="en"><kwd>urinary tract infection</kwd><kwd>cystitis in women</kwd><kwd>pyelonephritis in women</kwd><kwd>gestational pyelonephritis</kwd><kwd>antibiotic therapy for UTI</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>инфекция мочевыводящих путей</kwd><kwd>цистит у женщин</kwd><kwd>пиелонефрит у женщин</kwd><kwd>гестационный пиелонефрит</kwd><kwd>антибиотикотерапия ИМП</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Schmiemann G, Kniehl E, Gebhardt K, et al. The diagnosis of urinary tract infection: a systematic review. Dtsch Arztebl Int 2010;107:361–367.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Chu CM, Lowder JL. Diagnosis and treatment of urinary tract infections across age groups. Am J Obstet Gynecol. 2018;219:40–51.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Alós JI. Epidemiología y etiología de la infección urinaria comunitaria. Sensibilidad antimicrobiana de los principales patógenos y significado clínico de la resistencia. Enferm Infecc Microbiol Clin. 2005;23:3–8.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Guidelines for Perinatal Care. AAP, Elk Grove Village, IL; ACOG, Washington DC: American Academy of Pediatrics, American College of Obstetricians and Gynecologists; 2017. 8th ed:</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Yefet E, Bejerano A, Iskander R, Zilberman Kimhi T, Nachum Z. The Association between Gestational Diabetes Mellitus and Infections in Pregnancy-Systematic Review and Meta-Analysis. Microorganisms. 2023;11(8):1956.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Mazor-Dray E, Levy A, Schlaeffer F, Sheiner E. Maternal urinary tract infection: is it independently associated with adverse pregnancy outcome?. J Matern Fetal Neonatal Med. 2009(2):124–28.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Yan L, Jin Y, Hang H, Yan B. The association between urinary tract infection during pregnancy and preeclampsia: A meta-analysis. Medicine (Baltimore). 2018(36):e12192.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Gilstrap LC, Ramin SM. Urinary tract infections during pregnancy. Obstetrics and Gynecology Clinics of North America. 2001;28(3):581–591.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Rodriguez PN, Klein AS: Management of urolithiasis in pregnancy. Surg Gynecol Obstet. 1988;166:103–106.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Hill, J.B., et al. Acute pyelonephritis in pregnancy. Obstet Gynecol. 2005;105:18.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Bader, M.S., et al. An update on the management of urinary tract infections in the era of antimicrobial resistance. Postgrad Med, 2017. 129: 242.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Geerlings S.E. et al. SWAB Guidelines for Antimicrobial Therapy of Complicated Urinary Tract Infections in Adults. SWAB Guidelines, 2013.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Hooton T.M. et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:625.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Peterson J., et al. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006. Clin Ther. 2007;29:2215.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Rodríguez-Baño J, Picón E, Gijón P, Hernández JR, Ruíz M, Peña C, Almela M, Almirante B, Grill F, Colomina J, Giménez M, Oliver A, Horcajada JP, Navarro G, Coloma A, Pascual A; Spanish Network for Research in Infectious Diseases (REIPI). Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis. Clin Infect Dis. 2010;50(1):40–48.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>European Association of Urology Guidelines on Urological Infections, 2024 Edition. https://d56bochluxqnz.cloudfront.net/documents/full-guideline. EAU-Guidelines-on-Urological-Infections-2024.pdf.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Clinical recommendations «Urinary tract infection during pregnancy» of the Ministry of Health of the Russia</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>2022, https://cr.minzdrav.gov.ru/recomend/719_1. Russian (Клинические рекомендации «Инфекция мочевых путей при беременности» МЗ РФ, 2022 г., https://cr.minzdrav.gov.ru/recomend/719_1).</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Clinical recommendations «Cystitis in women» of the Ministry of Health of the Russia</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>2024, https://cr.minzdrav.gov.ru/recomend/14_3. Russian (Клинические рекомендации «Цистит у женщин» МЗ РФ, 2024 г., https://cr.minzdrav.gov.ru/recomend/14_3).</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Palagin I.S. et al. Antibiotic resistance of pathogens of community-acquired urinary tract infections in Russia: results of the multicenter study «DARMIS-2018». Clinical microbiology and antimicrobial chemotherapy. 2019;21(2):134–146. Russian (Палагин И.С. и соавт. Антибиотикорезистентность возбудителей внебольничных инфекций мочевых путей в России: результаты многоцентрового исследования «ДАРМИС-2018». Клиническая микробиология и антимикробная химиотерапия. 2019;21(2):134–146).</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>The AMRCloud platform. Dataset: DARMIS 2009-2011, 2017-2018 Interpretation (IPC/DD): EUCAST v11.0 (2021). https://app.amrcloud.net/rus/?id=darmis&amp;public=T. Russian (Платформа AMRCloud. Набор данных: ДАРМИС 2009-2011, 2017-2018 Интерпретация (МПК/DD): EUCAST v11.0 (2021). https://app.amrcloud.net/rus/?id=darmis&amp;public=T).</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Kresken M. et al. Comparative in vitro activity of oral antimicrobial agents against Enterobacteriaceae from patients with community-acquired urinary tract infections in three European countries. Clin Microbiol Infect 2016;22:63.e1–63.e5</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Bader MS, Loeb M, Leto D, Brooks AA. Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents. Postgrad Med. 2020;132(3):234–250. doi: 10.1080/00325481.2019.1680052.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Mulvey MA, Schilling JD, Hultgren SJ. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun. 2001;69(7):4572–79. doi: 10.1128/IAI.69.7.4572-4579.2001.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Dhakal BK, Kulesus RR, Mulvey MA. Mechanisms and consequences of bladder cell invasion by uropathogenic Escherichia coli. Eur J Clin Invest. 2008;38 Suppl 2:2–11. doi: 10.1111/j.1365-2362.2008.01986.x.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Lokshin K.L., Gevorkyan A.R., Evdokimov M.E. and others. Analysis of the effectiveness of standard antibiotic therapy and the risk of recurrence of acute uncomplicated cystitis in women of childbearing age. An open randomized comparative study. Consilium medicum. 2012;14(4):51–56. Russian (Локшин К.Л., Геворкян А.Р., Евдокимов М.Е. и др. Анализ эффективности стандартной антибиотикотерапии и риска рецидивирования острых неосложненных циститов у женщин детородного возраста. Открытое рандомизированное сравнительное исследование. Consilium medicum. 2012;14(4):51–56).</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Cunningham F., Leveno K., Bloom S., Hauth J., Gilstrap L., Wenstrom K. Renal and urinary disorders. in Williams Obstetric, Chapter 48, pp. 1093–1110, McGraw-Hill, New York, NY, USA, 22nd edition, 2005.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Dawkins J.C. et al. Acute Pyelonephritis in Pregnancy: A Retrospective Descriptive Hospital Based-Study. Pyelonephritis in Pregnancy: A Retrospective Descriptive Hospital Based-Study. ISRN Obstetrics and Gynecology. 2012;2012:519321.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Gilstrap L.C., Ramin S.M. Urinary tract infections during pregnancy. Obstetrics and Gynecology Clinics of North America. 2001;28(3):581–591.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Millar L.K., DeBuque L., Wing D.A. Uterine contraction frequency during treatment of pyelonephritis in pregnancy and subsequent risk of preterm birth. Journal of Perinatal Medicine. 2003;31(1):41–46.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Graham J.M., Oshiro B.T., Blanco J.D., Magee K.P. Uterine contractions after antibiotic therapy for pyelonephritis in pregnancy. American Journal of Obstetrics and Gynecology. 1993;168(2):577–580.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Cox S.M., Shelburne P., Mason R., Guss S., Cunningham F.G. Mechanisms of hemolysis and anemia associated with acute antepartum pyelonephritis. American Journal of Obstetrics and Gynecology. 1991;164(2):587–590.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>van Nieuwkoop C., Hoppe BP, Bonten TN, Van’t Wout JW, Aarts NJ, Mertens BJ, Leyten EM, Koster T, Wattel-Louis GH, Delfos NM, Ablij HC, Elzevier HW, van Dissel JT. Predicting the need for radiologic imaging in adults with febrile urinary tract infection. Clin Infect Dis. 2010;51(11):1266–72. doi: 10.1086/657071.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Cattrall JWS, Robinson AV, Kirby A. A systematic review of randomised clinical trials for oral antibiotic treatment of acute pyelonephritis. Eur J Clin Microbiol Infect Dis. 2018;37(12):2285-2291. doi: 10.1007/s10096-018-3371-y.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Strohmeier Y, Hodson EM, Willis NS, Webster AC, Craig JC. Antibiotics for acute pyelonephritis in children. Cochrane Database of Systematic Reviews 2014, Issue 7. Art. No.: CD003772. DOI: 10.1002/14651858.CD003772.pub4</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Pohl A. Modes of administration of antibiotics for symptomatic severe urinary tract infections. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD003237. DOI: 10.1002/14651858.CD003237.pub2.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Millar LK, Wing DA, Paul RH, Grimes DA. Outpatient treatment of pyelonephritis in pregnancy: a randomized controlled trial. Obstet Gynecol. 1995;86(4 Pt 1):560–64. doi: 10.1016/0029-7844(95)00244-l.</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Wing DA, Hendershott CM, Debuque L, Millar LK. A randomized trial of three antibiotic regimens for the treatment of pyelonephritis in pregnancy. Obstet Gynecol. 1998;92(2):249–53. doi: 10.1016/s0029-7844(98)00156-2.</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, Moran GJ, Nicolle LE, Raz R, Schaeffer AJ, Soper DE; Infectious Diseases Society of America; European Society for Microbiology and Infectious Diseases. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52(5):e103-20. doi: 10.1093/cid/ciq257.</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Hooton TM. Clinical practice. Uncomplicated urinary tract infection. N Engl J Med. 2012;366(11):1028-37. doi: 10.1056/NEJMcp1104429.</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Arakawa S, Kawahara K, Kawahara M, Yasuda M, Fujimoto G, Sato A, Yokokawa R, Yoshinari T, Rhee EG, Aoyama N. The efficacy and safety of tazobactam/ceftolozane in Japanese patients with uncomplicated pyelonephritis and complicated urinary tract infection. J Infect Chemother. 2019;25(2):104-110. doi: 10.1016/j.jiac.2018.10.009.</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Armstrong ES, Mikulca JA, Cloutier DJ, Bliss CA, Steenbergen JN. Outcomes of high-dose levofloxacin therapy remain bound to the levofloxacin minimum inhibitory concentration in complicated urinary tract infections. BMC Infect Dis. 2016;16(1):710. doi: 10.1186/s12879-016-2057-2.</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Carmeli Y, Armstrong J, Laud PJ, Newell P, Stone G, Wardman A, Gasink LB. Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study. Lancet Infect Dis. 2016;16(6):661-673. doi: 10.1016/S1473-3099(16)30004-4.</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Weintraub A.S. et al. Antenatal antibiotic exposure in preterm infants with necrotising enterocolitis. J. Perinatol. 2012;32(9):705–709.</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Ghidini A. et al. Does co-amoxiclav in preterm prom increase the risk of necrotising enterocolitis (NEC)? a meta-analysis. Am. J. Obstet. Gynecol. 2003;189(6):S170.</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Lokshin K.L. Drainage of the upper urinary tract in acute pyelonephritis in pregnant women: Why? To whom? How long? Bulletin of Urology. 2019;7(3):35-40. https://doi.org/10.21886/2308-6424-2019-7-3-35-40. Russian (Локшин К.Л. Дренирование верхних мочевых путей при остром пиелонефрите у беременных: Зачем? Кому? Как долго? Вестник урологии. 2019;7(3):35-40. https://doi.org/10.21886/2308-6424-2019-7-3-35-40).</mixed-citation></ref></ref-list></back></article>
